Literature DB >> 1948247

Erythropoietin therapy for sickle cell anemia in Jehovah's Witnesses.

B J Brooks, D S Hanson, P A Cryer, W J Hubbard, D Hooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1948247     DOI： 10.1097/00007611-199111000-00042

Source DB:  PubMed          Journal:  South Med J        ISSN： 0038-4348            Impact factor:   0.954


× No keyword cloud information.
  3 in total

1.  The dilemma of Jehovah's Witness children who need blood to survive.

Authors:  A Catlin
Journal:  HEC Forum       Date:  1996-07

2.  Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review.

Authors:  Jane A Little; Vicki R McGowan; Gregory J Kato; Kristine S Partovi; Jordan J Feld; Irina Maric; Sabrina Martyr; James G Taylor; Roberto F Machado; Theo Heller; Oswaldo Castro; Mark T Gladwin
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

3.  Successful Treatment of Severe Anemia using Erythropoietin in a Jehovah Witness with Non-Hodgkin Lymphoma.

Authors:  Alexandra Agapidou; Sofia Vakalopoulou; Theodosia Papadopoulou; Christina Chadjiaggelidou; Vasileia Garypidou
Journal:  Hematol Rep       Date:  2014-12-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.